Related Videos
Video
2025 SABCS Highlights: First-Line Tx for HER2+ Advanced Breast Cancer
Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the DESTINYBreast09, HER2-CLIMB, and PATINA CNS trials for first-line treatment in advanced breast cancer, which were presented at the 2025 San Antonio Breast Cancer Symposium.
Video
2025 San Antonio Breast Cancer Symposium Panel Discussion
Harold Burstein, MD, PhD; Sara Tolaney, MD, MPH; Nancy Lin, MD; Sarah Sammons, MD; Ana C. Garrido-Castro, MD; and Elizabeth Ann Mittendorf, MD, PhD, MHCM, discuss important breast cancer research presented at the 2025 San Antonio Breast Cancer Symposium.
Video
ESMO25 Breast Cancer Highlights: monarchE and NATALEE
Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the monarchE and NATALEE trials, investigating CDK4/6 inhibitors for high-risk, early stage, HR+ breast cancer.